Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $509.0300 (0.55%) ($507.1800 - $515.4650) on Wed. Nov. 25, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.33% (three month average) | RSI | 22 | Latest Price | $509.0300(0.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.4% a day on average for past five trading days. | Weekly Trend | REGN declines -5.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) XLV(42%) SPLV(36%) IVW(35%) SPY(35%) | Factors Impacting REGN price | REGN will decline at least -1.165% in a week (0% probabilities). VIXM(-21%) TBT(-7%) VXX(-6%) UUP(-6%) EDOC(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.165% (StdDev 2.33%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $547.23 | 5 Day Moving Average | $514.51(-1.07%) | 10 Day Moving Average | $530.1(-3.97%) | 20 Day Moving Average | $547.23(-6.98%) | To recent high | -17.9% | To recent low | 0.5% | Market Cap | $53.972b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |